China Cosmetics Formula Ingredients Analysis System
|
|
All cosmetics need apply
CFDA register, after get the approval of
CFDA then can be imported to China; Only 50%~60% INCI (International Nomenclature Cosmetic Ingredient) cosmetics ingredients are permitted to use in China by
CFDA, if products formula contain incompliance ingredients, will cause the fail of
CFDA registration. |
China CFDA Cosmetics Prohibitted Ingredients
:
CFDA No. |
Prohibitted Ingredient Name |
Ingredient Chinese Name |
1041 |
Phenazinium, 3,7-diamino-2,8-dimethyl-5-phenyl- (CAS No. 477-73-6)and its salts |
酚嗪鎓, 3,7-二氨基-2,8-二甲基-5-苯基-及其盐类 |
1042 |
Phenindione (INN) (CAS No. 83-12-5) |
苯茚二酮 |
1043 |
Phenmetrazine (INN) (CAS No. 134-49-6), its derivatives and salts |
芬美曲秦及其衍生物和盐类 |
1044 |
Phenol (CAS No. 108-95-2) |
苯酚 |
1045 |
Phenothiazin-5-ium, 3,7-bis(dimethylamino) (CAS No. 61-73-4)and its salts |
吩噻嗪-5-鎓, 3,7-双(二甲氨) 及其盐类 |
1046 |
Phenothiazine (INN) (CAS No. 92-84-2)and its compounds |
吩噻嗪及其化合物 |
1047 |
Phenoxazin-5-ium, 3,7-bis(diethylamino)- and its salts (CAS No. 47367-75-9 / CAS No. 33203-82-6) |
吩恶嗪-5-鎓, 3,7-双(二乙氨基)-及其盐类 |
1048 |
Phenprobamate (INN) (CAS No. 673-31-4) |
苯丙氨酯 |
1049 |
Phenprocoumon (INN) (CAS No. 435-97-2) |
苯丙香豆素 |
1050 |
Phenyl 4-hydroxybenzoate (INCI: Phenylparaben) |
羟苯苯酯 |
1051 |
Phenylbutazone (INN) (CAS No. 50-33-9) |
保泰松 |
1052 |
Phosphamidon (CAS No. 13171-21-6) |
磷胺(大灾虫) |
1053 |
Phosphorus (CAS No. 7723-14-0) and metal phosphides |
磷及金属磷化物 |
1054 |
Phytonadione (INCI); phytomenadione(INN) (CAS No. 84-80-0/ CAS No. 81818-54-4) |
维生素 K-1 |
1055 |
Picric acid (CAS No. 88-89-1) |
苦味酸(2,4,6-三硝基苯酚) |
1056 |
Picrotoxin (CAS No. 124-87-8) |
印防己毒素 |
1057 |
Pilocarpine (CAS No. 92-13-7) and its salts |
毛果云香碱及其盐类 |
1058 |
Pipazetate (INN) (CAS No. 2167-85-3)and its salts |
匹哌氮酯及其盐类 |
1059 |
Pipradrol (INN) (CAS No. 467-60-7)and its salts |
哌苯甲醇及其盐类 |
1060 |
Piprocurarium iodide (INN) (CAS No. 3562-55-8) |
哌库碘铵 |
Alphabet
Shortcut:
A
| B
| C
| D
| E
| F
| G
| H
| I
| G
| K
| L
| M
| N
| O
| P
| Q
| R
| S
| T
| U
| V
| W
| X
| Y
| Z
|
|
|
|
|
|